Surgery after chemotherapy: Gastric cancer;La chirurgie après chimiothérapie d'induction: Le cancer de l'estomac

Bulletin du Cancer

Volumn 98, Issue 1, 2011, Pages 31-35

  Flamein, Renaud ^a   Antomarchi, Olivier ^a   Pezet, Denis ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Gastric adenocarcinoma; N oadjuvant chemotherapy; Perioperative chemotherapy; Pretherapeutics evaluation

Indexed keywords

ANTHRACYCLINE; CISPLATIN; FLUOROURACIL; OXALIPLATIN; PRODRUG;

CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; GASTROINTESTINAL ENDOSCOPY; HUMAN; META ANALYSIS (TOPIC); MORBIDITY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PREOPERATIVE EVALUATION; REVIEW; STOMACH ADENOCARCINOMA; STOMACH BIOPSY;

EID: 79551615040     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1287     Document Type: Review

References (20)

1. http://www.invs.sante.fr/applicationsd/cancers/projections2010.
2. Ychou M, Pignon P, Lasser P, et al. Phase III preliminary results of preoperative fluorouracil and cisplatin versus surgery alone in adenocarcinoma of stomach and lower esophagus: FNLCC 94012-FFCD9703 trial. J Clin Oncol 2006 ASCO Annual Meeting Proceedings;24:4026.
3. Cunningham D, Allum W, Stenning S, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006 ; 355 : 11-20.
4. Piessen G, Messager M, Leteurtre E, Triboulet JP, Mariette C. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg 2009 ; 250 : 878-87.
5. Mitry E, Taieb J, Artru P, et al. Combination of folinic acid, 5-fluorouracil bolus and infusion, and Cisplatin (LV5-FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma. Ann Oncol 2004 ; 15 : 765-9. (Pubitemid 38720157)
6. De Vita F, OrdituraM, Matano E, et al. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer 2005 ; 92 : 1644-940.
7. Al-Batran SE, Hartmann JT, Probst S, et al. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 2008 ; 26 : 1435-42.
8. Cunningham D, Rao S, Starling N, et al. Randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer: the REAL 2 trial. J Clin Oncol 2006 ASCO Annual Meeting Proceedings;24:4017.
9. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.NEngl J Med 2001 ; 345 : 725-33.
10. Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T, & Southwest Oncology Group and the Gastric Intergroup. Surgical treatment variation in prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of under treatment. Ann Surg Oncol 2002 ; 9 : 278-86. (Pubitemid 34298633)
11. Macdonald JS, Benedetti J, Smalley S, Haller D, Hundahl S, Jessup J. Chemoradiation of resected gastric cancer: a 10 year follow-up of the phase III trial INTO116 (SWOG9008). J Clin Oncol 2009 ; 27(15s). [suppl; abstr 4515].
12. Gastric Group, Paoletti X, Oba K, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 2010 ; 303 : 1729-37.
13. Kumano S, Murakami T, Kim T, et al. T staging of gastric cancer: role of multi-detector row CT. Radiology 2005 ; 237 : 961-6.
14. Chen CY, Hsu JS,Wu DC, et al. Gastric cancer: preoperative local staging with 3D multi-detector row CT - correlation with surgical and histopathologic results. Radiology 2007 ; 242 : 472-82.
15. Bentrem D, Gerdes H, Tang L, Brennan M, Coit D. Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer. Ann Surg Oncol 2007 ; 14 : 1853-9. (Pubitemid 46870927)
16. Hwang S, Lee D, Lee S, et al. Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. Journal of Gastroenterology and Hepatology 2010 ; 25 : 512-8.
17. Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 2007 ; 8 : 797-805.
18. Sakurada A, Takahara T, Kwee T, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 2009 ; 19 : 1461-9.
19. Kwe RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol 2007 ; 25 : 2107-16.
20. Kwe RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer 2009 ; 12 : 6-22.